Capitalmind
Capitalmind
Actionable insights on equities, fixed-income, macros and personal finance Start 14-Days Free Trial
Actionable investing insights Get Free Trial

Month: April 2008

1 / 2

Banks and Corporates fight it out over derivatives. Banks will lose either way.

From Bloomberg: Jasmin Mehta says that when he told salesmen from ICICI Bank Ltd. he didn’t understand currency derivatives, they chauffeured him to a ...

ICICI FY08 EPS growth is 4%, Q4 EPS Contracts

ICICI Bank reveals it’s Q4 results and annual results for FY 08. What I’m concerned with is the EPS contraction in the fourth quarter. In Q3, ...

Can’t Believe Financial Statements Anymore

From FT (tip: Marc’s blog): Rules regarding how banks account for off-balance sheet interests are “irretrievably broken”, a senior group of ...

Reliance Power Bonus: Ex-Date is 30 May 2008

A number of you are searching for the record date of the Reliance Power Bonus issue and then hitting my blog. Note now that the management has announced it ...

Airtel's Auditor Notes: What To Make Of It?

From Airtel’s auditor’s report: Note 7 to these financial results, regarding the revaluation of investments in Bharti Infratel Limited (‘ ...

The Trust Is Gone

From Calculated Risk: Homebuyer’s were speculating with no money down. Mortgage brokers didn’t care because they would sell the loans immediately ...

Reader Comment: Sea of Red For Real Estate Lenders

Two comments that piqued my interest, on the CRR Hike post: Indian IT will be in X roads..and India will have a sub prime crisis of its own since many of these ...

CRR Hike And Rupee Woes

With today’s inflation figures coming out and a 7.14% inflation, RBI’s response has been to hike the Cash Reserve Ratio by 0.5% to 8% now. The CRR ...

Of Arrogance and Humility

Sometimes a online page pisses me off. Like when I dug into Ajit Dayal in my “Dishonest Truths” post. A little harshly, no doubt. I don’t ...

Orchid Up 16%, and Mudra’s on a roll as well

Orchid Chem is up 16% at Rs. 287 today. This is quite a spectacular move, for a stock I’d only written about yesterday. (Read: The Orchid Saga, Still ...